Sponsors

Email Print

Download Brochure

Full Conference Details Inside

Event Information

Related Events

Oligonucleotide Therapeutics Discovery

May 20-23, 2012
Peptide Discovery and Development

May 20-23, 2012
TIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

May 20-23, 2012

Find Another IBC Event

AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

CSS

The only event in Asia with comprehensive updates on therapeutics in development from major big pharma, biotech and academic scientists worldwide

February 28 - March 01,--> 2012 · Sheraton Miyako Hotel · Tokyo, Japan

Updated: January 31, 2012

Platinum Sponsor

Expertise. Innovation. Reliability. With over 15 years of oligonucleotide manufacture, more than 1000 sequences produced at scale, and industry leading experience in validation and commercial product requirements, Avecia OligoMedicines℠ is proud to continue our tradition of 'Experience and Reliability from the First Gram.' As the oligo market continues to evolve, we are excited to advance with it as a new member of the Nitto Denko Corporation. Our shared commitment to the future is driven by innovative ideas and flexible solutions, designed to provide our customers with the best in service, quality, and technology. From pre-clinical stages to commercial launch, you can count on Avecia OligoMedicines℠, a Nitto Denko Company.

Silver Sponsors
	Agilent's Nucleic Acid Solutions Division offers industry leading experience to efficiently advance your lead oligo candidates from clinic to market with a common goal of patient health and safety. With Agilent, you always have peace of mind by partnering with a company that has the financial resources, stability and vision required for long-term success. Contact us at: pdl-boulderinfo@agilent.com and find out why the world's most revolutionary biotech companies and their Big Pharma partners are choosing Agilent Technologies to develop and commercialize their oligo APIs.
	Established in 1981, ChemGenes, the industry leader in Oligonucleotide Reagent manufacturing, has consistently provided the highest quality Phosphoramidites and Solid Supports in the market. Our Massachusetts facility is setup for therapeutic grade phosphoramidites and DNA/RNA synthesis products for GMP grade oligonucleotide manufacturing. Currently, our bulk synthesis capacities are 150kg/base yearly for 2'-O-Methyl and DNA phosphoramidites and 60kg/base yearly for RNA phosphoramidites. Additionally, ChemGenes carries the widest variety of modified phosphoramidites and supports currently used in oligonucleotide synthesis including Microarray Technology, Oligonucleotide Therapeutics, Oligonucleotide Based Probes and other areas of Nucleic Acid research. ChemGenes remains devoted to providing you with invaluable customer service and comprehensive technical support.
	Lonza offers the life sciences market a full range of bioresearch products, development services and manufacturing for active ingredients. For 30 years we have been helping companies increase product quality, improve production processes, navigate regulatory hurdles, lower costs, and get to market faster. From early development to in-market supply, our complete development services, industry-leading manufacturing processes, broad technology platform and lifecycle management experience can help take your product to the next level. For flexible, high-quality manufacturing, development services and products, we can help.

Bronze Sponsors
	BioSpring is a company in the chemical and biotechnology sectors producing oligonucleotides for us in therapeutics and diagnostics as well as for research purposes. The company offers a broad range of manufacturing scales ranging from small mg amounts for research and development up to several kg for clinical trials.
	GeneDesign offers contract manufacturing of various oligonucleotides including PEGylation and Peptide conjugation from screening use to hundreds gram under the control of GMP guideline with sterilized condition. We can contribute to your successful oligo therapeutics development. We also have launched new oligo-synthesizer based on well expertise for long RNA manufacturing.
	Girindus is dedicated to being your preferred oligonucleotide supplier from preclinical through commercial production. We simplify your drug development by providing process and analytical method development, validation, ICH stability studies, preparation of CMC documentation, oligo-peptide conjugation, radiolabeling and synthesis of small molecules all at our FDA inspected site in Cincinnati.

Session Sponsors

Spotlight Presentation Sponsors

Networking Reception Co-Sponsors

Badge and Lanyard Sponsor